AGArya Gupta

Arya Gupta

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Arya Gupta has a total of 64 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Exploring the gaps and opportunities for development of an AMR educational package for higher education

    by Nzelle Delphine Kayem, Charlotte Cornbill, Muriel Dresen, Arya Gupta, Kristina Kadlec, Priyanka More, Afolake Atinuke Olanbiwoninu, Désirée Schaaf, Raju Sekar, Christina Stylianou, et al.

    Antimicrobial resistance (AMR) is a complex and rapidly evolving global health challenge that requires well-trained professionals within a One Health framework. However, AMR education remains fragmented, with limited interdisciplinary integration and inconsistencies across disciplines. Although AMR is included in undergraduate and postgraduate curricula in human medicine, veterinary medicine, biological sciences, and pharmacology, the educational focus differs substantially between fields. Moreover, teaching focuses on biomedical and pharmacological aspects, while social, behavioural, and policy dimensions are often underrepresented, limiting the ability to address AMR as a multifaceted societal challenge. To identify gaps in AMR teaching, associated challenges and unmet educational resource needs, we conducted a three-month international survey among professionals from diverse scientific fields involved in AMR teaching. A total of 85 professionals participated in the survey, of whom 94% were actively involved in AMR teaching. AMR was most often taught within microbiology (35%) or health-related (33%) courses and was typically presented as few lectures within a module (33%). Although the general perception was that engaging teaching approaches, such as case-based learning, better support effective learning, many participants (31%) reported relying primarily on traditional lecture-based materials. Furthermore, the survey identified limited curriculum time, behavioural barriers, and funding constraints as the principle challenges to effective education. Overall, these findings indicate a strong demand for additional teaching resources, particularly interactive and application-oriented materials that support active learning and interdisciplinary education. This knowledge will support the development of an open educational resource (OER)-based interactive online educational platform, designed to enhance AMR education within a One Health context and support the training of future health professionals.

  • Open Access

    Exploring the gaps and opportunities for development of an AMR educational package for higher education

    by Nzelle Delphine Kayem, Charlotte Cornbill, Muriel Dresen, Arya Gupta, Kristina Kadlec, Priyanka More, Afolake Atinuke Olanbiwoninu, Désirée Schaaf, Raju Sekar, Christina Stylianou, et al.

    Antimicrobial resistance (AMR) is a complex and rapidly evolving global health challenge that requires well-trained professionals within a One Health framework. However, AMR education remains fragmented, with limited interdisciplinary integration and inconsistencies across disciplines. Although AMR is included in undergraduate and postgraduate curricula in human medicine, veterinary medicine, biological sciences, and pharmacology, the educational focus differs substantially between fields. Moreover, teaching focuses on biomedical and pharmacological aspects, while social, behavioural, and policy dimensions are often underrepresented, limiting the ability to address AMR as a multifaceted societal challenge. To identify gaps in AMR teaching, associated challenges and unmet educational resource needs, we conducted a three-month international survey among professionals from diverse scientific fields involved in AMR teaching. A total of 85 professionals participated in the survey, of whom 94% were actively involved in AMR teaching. AMR was most often taught within microbiology (35%) or health-related (33%) courses and was typically presented as few lectures within a module (33%). Although the general perception was that engaging teaching approaches, such as case-based learning, better support effective learning, many participants (31%) reported relying primarily on traditional lecture-based materials. Furthermore, the survey identified limited curriculum time, behavioural barriers, and funding constraints as the principle challenges to effective education. Overall, these findings indicate a strong demand for additional teaching resources, particularly interactive and application-oriented materials that support active learning and interdisciplinary education. This knowledge will support the development of an open educational resource (OER)-based interactive online educational platform, designed to enhance AMR education within a One Health context and support the training of future health professionals.

  • Open Access

    Identification of a novel DNA repair inhibitor using an in silico driven approach shows effective combinatorial activity with genotoxic agents against multidrug‐resistant Escherichia coli

    by Lorenzo Bernacchia, Antoine Paris, Arya Gupta, Robert J. Charman, Jake McGreig, Mark N. Wass, Neil M. Kad

    Increasing antimicrobial drug resistance represents a global existential threat. Infection is a particular problem in immunocompromised individuals, such as patients undergoing cancer chemotherapy, due to the targeting of rapidly dividing cells by antineoplastic agents. We recently developed a strategy that targets bacterial nucleotide excision DNA repair (NER) to identify compounds that act as antimicrobial sensitizers specific for patients undergoing cancer chemotherapy. Building on this, we performed a virtual drug screening of a ~120,000 compound library against the key NER protein UvrA. From this, numerous target compounds were identified and of those a candidate compound, Bemcentinib (R428), showed a strong affinity toward UvrA. This NER protein possesses four ATPase sites in its dimeric state, and we found that Bemcentinib could inhibit UvrA's ATPase activity by ~90% and also impair its ability to bind DNA. As a result, Bemcentinib strongly diminishes NER's ability to repair DNA in vitro. To provide a measure of in vivo activity we discovered that the growth of Escherichia coli MG1655 was significantly inhibited when Bemcentinib was combined with the DNA damaging agent 4‐NQO, which is analogous to UV. Using the clinically relevant DNA‐damaging antineoplastic cisplatin in combination with Bemcentinib against the urological sepsis‐causing E. coli strain EC958 caused complete growth inhibition. This study offers a novel approach for the potential development of new compounds for use as adjuvants in antineoplastic therapy.


  • Open Access

    Culture media, DMSO and efflux affect the antibacterial activity of cisplatin and oxaliplatin

    by A. Gupta, L. Bernacchia, N.M. Kad

    Cisplatin was originally discovered through its antibacterial action and subsequently has found use as a potent broad-spectrum anticancer agent. This study determines the effect of growth media and solvent on the antibacterial activity of cisplatin and its analogue, oxaliplatin. Escherichia coli MG1655 or MG1655 ΔtolC was treated with the platinum compounds under different conditions and susceptibility was determined. Our results showed that DMSO reduced the activity of cisplatin by fourfold (MIC 12·5 mg l−1) compared with 0·9% NaCl-solubilized cisplatin (MIC 3·12 mg l−1) when tested in MOPS. Surprisingly, complete loss of activity was observed in Mueller–Hinton Broth II (MHB II). By supplementing MOPS with individual components of MHB II such as the sulphur-containing amino acids, l-cysteine and l-methionine, individually or in combination reduced activity by ≥8-fold (MIC ≥25 mg l−1). Oxaliplatin was less active against E. coli (MIC 100 mg l−1) but exhibited similar inactivation in the presence of DMSO, MHBII or MOPS spiked with l-cysteine and l-methionine (MIC ≥400 mg l−1). Our data suggest that the antibacterial activity of cisplatin and oxaliplatin is modulated by both choice of solvent and composition of growth media. We demonstrate that this is primarily due to sulphur-containing amino acids cysteine and methionine, an essential component of the recommended media for testing antimicrobial susceptibility, MHBII.


  • Open Access

    Growth-Dependent Predation and Generalized Transduction of Antimicrobial Resistance by Bacteriophage

    by Quentin J. Leclerc, Jacob Wildfire, Arya Gupta, Jodi A. Lindsay, Gwenan M. Knight

    Bacteriophage (phage), viruses that can infect and kill bacteria, are being investigated through phage therapy as a potential solution to the threat of antimicrobial resistance (AMR). In reality, however, phage are also natural drivers of bacterial evolution by transduction when they accidentally carry nonphage DNA between bacteria.


  • Open Access

    The dual nature of bacteriophage: growth-dependent predation and generalised transduction of antimicrobial resistance

    by Quentin J Leclerc, Jacob Wildfire, Arya Gupta, Jodi A Lindsay, Gwenan M Knight

    Bacteriophage (“phage”) are both predators and evolutionary drivers for bacteria, notably contributing to the spread of antimicrobial resistance (AMR) genes by generalised transduction. Our current understanding of the dual nature of this relationship is limited. We used an interdisciplinary approach to quantify how these interacting dynamics can lead to the evolution of multi-drug resistant bacteria. We co-cultured two strains of Methicillin-resistant Staphylococcus aureus , each harbouring a different antibiotic resistance gene, with 80α generalized transducing phage. After a growth phase of 8h, bacteria and phage surprisingly coexisted at a stable equilibrium in our culture, the level of which was dependent on the starting concentration of phage. We detected double-resistant bacteria as early as 7h, indicating that transduction of AMR genes had occurred. We developed multiple mathematical models of the bacteria and phage relationship, and found that phage-bacteria dynamics were best captured by a model in which the phage burst size decreases as the bacteria population reaches stationary phase, and where phage predation is frequency-dependent. We estimated that one in every 10 8 new phage generated was a transducing phage carrying an AMR gene, and that double-resistant bacteria were always predominantly generated by transduction rather than by growth. Our results suggest a shift in how we understand and model phage-bacteria dynamics. Although rates of generalised transduction could be interpreted as too rare to be significant, they are sufficient to consistently lead to the evolution of multi-drug resistant bacteria. Currently, the potential of phage to contribute to the growing burden of AMR is likely underestimated.


  • Open Access

    Acquired Nisin Resistance in Staphylococcus aureus Involves Constitutive Activation of an Intrinsic Peptide Antibiotic Detoxification Module

    by Christopher P. Randall, Arya Gupta, Bret Utley-Drew, Siu Yi Lee, Genevieve Morrison-Williams, Alex J. O’neill

    NIS and related bacteriocins are of interest as candidates for the treatment of human infections caused by Gram-positive pathogens such as Staphylococcus aureus . An important liability of NIS in this regard is the ease with which S. aureus acquires resistance. Here we establish that this organism naturally possesses the cellular machinery to detoxify NIS but that the ABC transporter responsible (VraDE) is not ordinarily produced to a degree sufficient to yield substantial resistance. Acquired NIS resistance mutations prompt activation of the regulatory circuit controlling expression of vraDE , thereby unmasking an intrinsic resistance determinant. Our results provide new insights into the complex mechanism by which expression of vraDE is regulated and suggest that a potential route to overcoming the resistance liability of NIS could involve chemical modification of the molecule to prevent its recognition by the VraDE transporter.


  • Open Access

    Design, synthesis and microbiological evaluation of novel compounds as potential Staphylococcus aureus phenylalanine tRNA synthetase inhibitors

    by Samar S. Elbaramawi, Casey Hughes, Jennifer Richards, Arya Gupta, Samy M. Ibrahim, El-Sayed M. Lashine, Mohamed E. El-Sadek, Alex J. O’Neill, Mandy Wootton, James M. Bullard, et al.

    As the resistance of Staphylococcus aureus to antibiotics represents a major threat to global health, anti-infectives with novel mechanisms must be developed. Novel compounds were generated as potential phenylalanine tRNA synthetase (PheRS) inhibitors based on the published homology model of S. aureus PheRS to aid the design process using Molecular Operating Environment (MOE) software. PheRS was selected as it is structurally unique enzyme among the aminoacyl-tRNA syntheases (aaRS), it is considerably different from human cytosolic and human mitochondrial aaRS and it is essential and conserved across bacterial species. The designed compounds were synthesized according to different clear schemes. The compounds were confirmed by 1H NMR, 13C NMR, HRMS and/or microanalysis, and they were microbiologically evaluated.


  • N-Leucinyl Benzenesulfonamides as Structurally Simplified Leucyl-tRNA Synthetase Inhibitors

    by Michael H. Charlton, Rihards Aleksis, Adélaïde Saint-Leger, Arya Gupta, Einars Loza, Lluís Ribas de Pouplana, Ilze Kaula, Daina Gustina, Marina Madre, Daina Lola, et al.

    N-Leucinyl benzenesulfonamides have been discovered as a novel class of potent inhibitors of E. coli leucyl-tRNA synthetase. The binding of inhibitors to the enzyme was measured by using ITC. This provided information on enthalpy and entropy contributions to binding, which, together with docking studies, were used for SAR analysis. Enzymatic assays revealed that N-leucinyl benzene-sulfonamides display remarkable selectivity for E. coli leucyl-tRNA synthetase compared to S. aureus and human orthologs. The simplest analog of the series _ N-leucinyl benzenesulfonamide (R = H) showed the highest affinity against E. coli leucyl-tRNA syn-thetase and also exhibited antibacterial activity against gram-negative pathogens (the best MIC = 8 ug/mL, E. coli ATCC 25922) which renders it as a promising template for antibacterial drug discovery.